搜索临床试验以:EGFRvIII-specific hinge-optimized CD3 ζ-stimulatory/41BB-co-stimulatory Chimeric Antigen Receptor au
总计6个结果
-
Chembrain LTDUniversity of Oulu; Jyväskylä Central Hospital; Apollo Hospital, New Delhi, India主动,不招人胶质母细胞瘤 | 多形性胶质母细胞瘤 | 胶质瘤,恶性芬兰, 印度
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)主动,不招人复发性胶质母细胞瘤 | 复发性恶性胶质瘤 | 难治性恶性胶质瘤 | 复发性 WHO III 级神经胶质瘤 | 复发性 WHO II 级神经胶质瘤 | 难治性胶质母细胞瘤 | 难治性 WHO II 级神经胶质瘤 | 难治性 WHO III 级神经胶质瘤美国
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Jonsson Comprehensive Cancer CenterParker Institute for Cancer Immunotherapy; California Institute for Regenerative Medicine (CIRM) 和其他合作者招聘中乳腺癌 | 神经内分泌肿瘤 | 肺腺癌 | 转移性黑色素瘤 | 头颈部鳞状细胞癌 | 难治性恶性实体瘤 | 甲状腺癌 | 嗜铬细胞瘤 | 复发性恶性实体瘤 | 转移性恶性实体瘤 | 病理学阶段 IIIC 皮肤黑色素瘤 AJCC v8 | 胰腺神经内分泌肿瘤 | 葡萄膜黑色素瘤 | 副神经节瘤 | 肾上腺皮质癌 | 病理学 IV 期皮肤黑色素瘤 AJCC v8 | 肢端黑色素瘤美国